Oliver Robert, Friday Ellen, Turturro Francesco, Welbourne Tomas
Department of Molecular and Cellular Physiology, LSUHSC, Shreveport, LA 71130, USA.
Cell Physiol Biochem. 2008;22(5-6):475-86. doi: 10.1159/000185496. Epub 2008 Dec 9.
To determined the mechanism(s) through which troglitazone induces cytosolic acidification and glutamine-dependent ammoniagenesis in pig kidney derived LLC-PK1 cells.
Acute experiments measured acid extrusion, acid production and simultaneous Extracellular Signal-Regulated Kinase activation. TRO-enhanced acid production was correlated with mitochondrial membrane potential and rotenone and 5-(N-ethyl-N-isopropyl) amiloride, were employed to test specifically the role of Complex I proton pumping. Chronic experiments correlated inhibitors of Complex I with prevention of TRO-increased ammoniagenesis and affects on glutamine metabolism.
Exposure to TRO acutely activated Extracellular Signal-Regulated Kinase in a dose dependent manner associated with a fall in spontaneous cytosolic pH. Cytosolic acidosis was associated with both an increase in acid production and inhibition of sodium/hydrogen ion exchanger -mediated acid extrusion. Preventing TRO-induced Extracellular Signal-Regulated Kinase activation with Mitogen Activated Protein Kinase Kinase inhibitors blocked the increase in acid production, restored sodium/hydrogen ion exchanger-activity and prevented cytosolic acidification. Mechanistically, increased acid production was associated with a rapid mitochondrial depolarization and Complex I proton pumping. Blocking Extracellular Signal-Regulated Kinase activation prevented both the fall in Psim and the increased acid production suggesting that the former underlies the accelerated mitochondrial 'acid production'. Mitochondrial Complex I inhibitors EIPA and rotenone prevented increased acid production despite Extracellular Response Kinase activation and reduced sodium/hydrogen ion activity. Inhibition of Complex I prevented TRO's effects on glutamine metabolism.
TRO induces cellular acidosis through Extracellular Signal-Regulated Kinase activation-associated acid production and impaired acid extrusion. Acutely, increased acid production reflects mitochondrial Complex I proton pumping into the cytosol while chronically Complex I activity appears coupled to mitochondrial glutamate uptake and oxidation to ammonium at the expense of cytosolic transamination and alanine formation in these proximal tubule-like cells.
确定曲格列酮在猪肾源LLC-PK1细胞中诱导胞质酸化和谷氨酰胺依赖性氨生成的机制。
急性实验测量酸分泌、酸生成以及细胞外信号调节激酶的同时激活。曲格列酮增强的酸生成与线粒体膜电位相关,鱼藤酮和5-(N-乙基-N-异丙基)阿米洛利用于特异性测试复合体I质子泵的作用。慢性实验将复合体I抑制剂与预防曲格列酮增加的氨生成以及对谷氨酰胺代谢的影响相关联。
暴露于曲格列酮可急性激活细胞外信号调节激酶,呈剂量依赖性,同时伴有自发胞质pH值下降。胞质酸中毒与酸生成增加和钠/氢离子交换体介导的酸分泌抑制均相关。用丝裂原活化蛋白激酶激酶抑制剂阻止曲格列酮诱导的细胞外信号调节激酶激活,可阻断酸生成增加,恢复钠/氢离子交换体活性并防止胞质酸化。从机制上讲,酸生成增加与线粒体快速去极化和复合体I质子泵有关。阻止细胞外信号调节激酶激活可防止线粒体膜电位下降和酸生成增加,表明前者是线粒体“酸生成”加速的基础。线粒体复合体I抑制剂EIPA和鱼藤酮可防止酸生成增加,尽管细胞外反应激酶被激活,并降低了钠/氢离子活性。抑制复合体I可阻止曲格列酮对谷氨酰胺代谢的影响。
曲格列酮通过细胞外信号调节激酶激活相关的酸生成和酸分泌受损诱导细胞酸中毒。急性时,酸生成增加反映线粒体复合体I将质子泵入胞质,而慢性时,复合体I活性似乎与线粒体谷氨酸摄取和氧化为铵有关,代价是这些近端小管样细胞中的胞质转氨作用和丙氨酸形成。